GeneNews (TSE:GEN) Stock Price Up 9.1%

GeneNews Ltd (TSE:GEN) shares rose 9.1% on Monday . The stock traded as high as C$0.12 and last traded at C$0.12. Approximately 745,435 shares changed hands during mid-day trading, a decline of 51% from the average daily volume of 1,520,729 shares. The stock had previously closed at C$0.11.

The stock has a market cap of $21.45 million and a P/E ratio of -1.62.

WARNING: “GeneNews (TSE:GEN) Stock Price Up 9.1%” was originally posted by Baseball Daily News and is the property of of Baseball Daily News. If you are reading this piece of content on another website, it was illegally copied and republished in violation of United States and international trademark & copyright law. The original version of this piece of content can be read at

GeneNews Company Profile (TSE:GEN)

GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.

Featured Article: Cost of Goods Sold (COGS)

Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with's FREE daily email newsletter.